Single-Center Experience with Ifosfamide Monotherapy as Second-Line Treatment of Recurrent/Metastatic Osteosarcoma-论文-万方医学网

首页> > Single-Center Experience with Ifosfamide Monotherapy as Second-Line Treatment of Recurrent/Metastatic Osteosarcoma

Single-Center Experience with Ifosfamide Monotherapy as Second-Line Treatment of Recurrent/Metastatic Osteosarcoma

导出原文传递

翻译打印收藏纠错

第一作者： Verschoor, Arie Jan

作者： Verschoor, Arie Jan ^[1] ; Speetjens, Frank M. ^[2] ; Dijkstra, P. D. Sander ^[3] ; Fiocco, Marta ^[4] ; Van de Sande, Michiel A. J. ; Bovee, Judith V. M. G. ; Gelderblom, Hans

作者单位： Leiden Univ,Leiden Univ, Dept Med Oncol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands ^[1] Leiden Univ,Leiden Univ, Dept Orthopaed Surg, Leiden, Netherlands ^[2] Leiden Univ,Leiden Univ, Dept Biomed Data Sci, Leiden, Netherlands ^[3] Leiden Univ,Leiden Univ, Dept Pathol, Leiden, Netherlands ^[4]

关键词 Osteosarcoma Chemotherapy Ifosfamide Survival Metastasis HIGH-DOSE IFOSFAMIDE PEDIATRIC-ONCOLOGY-GROUP HIGH-GRADE OSTEOSARCOMA SOFT-TISSUE SARCOMA PROGNOSTIC-FACTORS PHASE-II CHEMOTHERAPY ETOPOSIDE BONE SURVIVAL

发布时间 2022-10-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Single-Center Experience with Ifosfamide Monotherapy as Second-Line Treatment of Recurrent/Metastatic Osteosarcoma

相似文献

同项目论文

相关期刊

检索历史 清除

Single-Center Experience with Ifosfamide Monotherapy as Second-Line Treatment of Recurrent/Metastatic Osteosarcoma

相似文献

同项目论文

相关期刊

检索历史清除